SCHEMBL4834967

SCHEMBL4834967

Cc1cnc(NC(CO)c2ccc(F)cc2)nc1Nc1cc(C2CC2)[nH]n1

nearest known ligand 0.80

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 15/20 0.80
IGF1R P08069 5/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4065423 1.00 NTRK1 (0.80) NTRK1IGF1R
SCHEMBL4640146 0.94 NTRK1 (0.73) NTRK1IGF1R
SCHEMBL23216996 0.91 NTRK1 (0.83) NTRK1IGF1R
SCHEMBL3342109 0.91 NTRK1 (0.83) NTRK1IGF1R
SCHEMBL4144533 0.89 NTRK1 (0.83) NTRK1IGF1R
SCHEMBL4144068 0.89 NTRK1 (1.00) NTRK1IGF1R
SCHEMBL4147228 0.89 NTRK1 (1.00) NTRK1IGF1R
SCHEMBL4144674 0.89 NTRK1 (1.00) NTRK1IGF1R
SCHEMBL4160280 0.89 NTRK1 (0.83) NTRK1IGF1R
SCHEMBL4072344 0.89 NTRK1 (0.80) NTRK1IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1877057-A1 USE OF PYRAZOLYL-PYRIMIDINE DERIVATIVES IN THE TREATMENT OF PAIN AstraZeneca AB (SE) 2008-01-16 EP disclosed
WO-2006115452-A1 USE OF PYRAZOLYL-PYRIMIDINE DERIVATIVES IN THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2006-11-02 WO disclosed